Government urged to re-establish pharmacoeconomics program

The government will have to re-evaluate the economic effectiveness of antihypertensive agents by clinicians who can induce a clinical rationale based on fair and transparent standpoint, the local two organizations said in a joint statement on May 24.

The Korea Pharmaceutical Manufacturers Association and the Korea Research-based Pharmaceutical Industry Association claimed that the preliminar...